Adaptimmune Therapeutics shares owned by Susquehanna International
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Susquehanna International
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $40k | 308k | 0.13 |
| 2025-06-30 | $13k | 52k | 0.24 |
| 2025-03-31 | $6.5k | 33k | 0.20 |
| 2024-12-31 | $26k | 49k | 0.54 |
| 2024-09-30 | $211k | 222k | 0.95 |
| 2024-06-30 | $270k | 277k | 0.97 |
| 2024-03-31 | $111k | 70k | 1.58 |
| 2023-09-30 | $130k | 167k | 0.78 |
| 2023-06-30 | $168k | 182k | 0.93 |
| 2022-12-31 | $41k | 28k | 1.46 |
| 2022-06-30 | $293k | 172k | 1.70 |
| 2022-03-31 | $405k | 197k | 2.06 |
| 2021-12-31 | $728k | 194k | 3.75 |
| 2021-09-30 | $2.2M | 422k | 5.17 |
| 2021-06-30 | $977k | 230k | 4.26 |
| 2021-03-31 | $1.6M | 304k | 5.31 |
| 2020-12-31 | $2.2M | 411k | 5.39 |
| 2020-09-30 | $2.2M | 274k | 7.98 |
| 2020-06-30 | $4.5M | 445k | 10.01 |
| 2018-09-30 | $3.3M | 247k | 13.56 |
| 2018-06-30 | $1.3M | 110k | 11.86 |
| 2018-03-31 | $2.2M | 193k | 11.23 |
| 2017-12-31 | $267k | 40k | 6.71 |
| 2017-09-30 | $85k | 10k | 8.17 |
| 2016-12-31 | $65k | 16k | 4.08 |
| 2015-12-31 | $131k | 11k | 12.08 |